| Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant N Andrews, J Stowe, F Kirsebom, S Toffa, T Rickeard, E Gallagher, ... New England Journal of Medicine 386 (16), 1532-1546, 2022 | 2160 | 2022 |
| Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis RM Viner, OT Mytton, C Bonell, GJ Melendez-Torres, J Ward, L Hudson, ... JAMA pediatrics 175 (2), 143-156, 2021 | 1116 | 2021 |
| Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 A Singanayagam, M Patel, A Charlett, JL Bernal, V Saliba, J Ellis, ... Eurosurveillance 25 (32), 2001483, 2020 | 1041 | 2020 |
| Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis B Chmielewska, I Barratt, R Townsend, E Kalafat, J van der Meulen, ... The Lancet Global Health 9 (6), e759-e772, 2021 | 1039 | 2021 |
| Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study OV Swann, KA Holden, L Turtle, L Pollock, CJ Fairfield, TM Drake, S Seth, ... bmj 370, 2020 | 733 | 2020 |
| Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study PA Waight, NJ Andrews, SN Ladhani, CL Sheppard, MPE Slack, E Miller The Lancet infectious diseases 15 (5), 535-543, 2015 | 688 | 2015 |
| Duration of protection against mild and severe disease by Covid-19 vaccines N Andrews, E Tessier, J Stowe, C Gower, F Kirsebom, R Simmons, ... New England Journal of Medicine 386 (4), 340-350, 2022 | 614 | 2022 |
| Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study NJ Andrews, PA Waight, P Burbidge, E Pearce, L Roalfe, M Zancolli, ... The Lancet infectious diseases 14 (9), 839-846, 2014 | 554 | 2014 |
| Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study SN Ladhani, S Collins, A Djennad, CL Sheppard, R Borrow, NK Fry, ... The Lancet Infectious Diseases 18 (4), 441-451, 2018 | 534 | 2018 |
| Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome S Ladhani, CL Joannou, DP Lochrie, RW Evans, SM Poston Clinical microbiology reviews 12 (2), 224-242, 1999 | 481 | 1999 |
| Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection J Zuo, AC Dowell, H Pearce, K Verma, HM Long, J Begum, F Aiano, ... Nature immunology 22 (5), 620-626, 2021 | 440 | 2021 |
| COVID-19 vaccination during pregnancy: coverage and safety H Blakeway, S Prasad, E Kalafat, PT Heath, SN Ladhani, K Le Doare, ... American journal of obstetrics and gynecology 226 (2), 236. e1-236. e14, 2022 | 424 | 2022 |
| Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries … AB Brueggemann, MJJ van Rensburg, D Shaw, ND McCarthy, KA Jolley, ... The Lancet Digital Health 3 (6), e360-e370, 2021 | 422 | 2021 |
| SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes A Khalil, E Kalafat, C Benlioglu, P O'Brien, E Morris, T Draycott, ... EClinicalMedicine 25, 2020 | 409 | 2020 |
| The changing and dynamic epidemiology of meningococcal disease SA Halperin, JA Bettinger, B Greenwood, LH Harrison, J Jelfs, ... Vaccine 30, B26-B36, 2012 | 407 | 2012 |
| SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England SA Ismail, V Saliba, JL Bernal, ME Ramsay, SN Ladhani The Lancet Infectious Diseases 21 (3), 344-353, 2021 | 372 | 2021 |
| Non-typeable Haemophilus influenzae, an under-recognised pathogen J Van Eldere, MPE Slack, S Ladhani, AW Cripps The Lancet infectious diseases 14 (12), 1281-1292, 2014 | 363 | 2014 |
| Presentation of vitamin D deficiency S Ladhani, L Srinivasan, C Buchanan, J Allgrove Archives of disease in childhood 89 (8), 781-784, 2004 | 362 | 2004 |
| Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards … JM Davies, MPN Lewis, J Wimperis, I Rafi, S Ladhani, PHB Bolton‐Maggs British journal of haematology 155 (3), 308-317, 2011 | 356 | 2011 |
| Changes in white blood cells and platelets in children with falciparum malaria: relationship to disease outcome S Ladhani, B Lowe, AO Cole, K Kowuondo, CRJC Newton British journal of haematology 119 (3), 839-847, 2002 | 354 | 2002 |
